論文代寫：衛生保健

論文代寫：衛生保健

衛生保健是人類的基本必需品之一。世界上大多數發展中國家和欠發達國家都迫切需要製定政策來支持該國的衛生保健制度。據記錄，很大一部分人沒有得到適當的保健設施或藥物。在非洲和亞洲某些地區，真實的情況是，人們生活在可怕的環境中，由於慢性疾病而有死亡的危險(Alwan, 2011)，因為他們沒有足夠的必要藥物來治愈他們的疾病。根據本文所討論的政策和學術研究，製藥公司與窮國的藥物狀況之間存在著顯著的關係。製藥公司可以在解決藥物問題上發揮有效作用(Dumit, 2012)。本文討論了亞洲和非洲欠發達地區的潛在問題以及製藥公司在消除這些問題方面的預期作用。

論文代寫：衛生保健

亞洲和非洲國​​家中有許多是世界上的窮人、高人口和低工資階層。通過與Ashcroft(2002)的研究，生活在非洲最貧窮國家的大多數人無法負擔基本藥物的價格。根據非洲的實際情況，HIV是非洲最常見的問題。 Kevin(2009)強調了非洲基本藥物的一個問題，即生產HIV藥物的製造商在該國壟斷和控製藥物的價格。數據顯示，如果艾滋病患者堅持治療，他們可能會平均活24年。在此期間，醫療費用需要60多萬美元，平均每年支出25200美元(Bor et al, 2013)。對絕大多數艾滋病患者來說，醫療支出是負擔不起的。不僅住在這一地區的病人負擔不起治療費用，而且非洲政府也負擔不起治療艾滋病毒所需的巨額資金。

論文代寫：衛生保健

Health care is one of the basic necessities of human beings. Most of the developing and under developed countries of the world are in urge of designing the policies to support the health care system of the country. It has been recorded that a large portion of human population does not receive proper health care facilities or medication. In the areas like Africa and certain parts of Asia, the real situation is that people are living in terrible conditions with the risk of death due to chronic diseases (Alwan, 2011), as they do not get enough essential medications to heal their disease. According to the policies and academic research discussed in this article, there is a significant relationship between the pharmaceutical companies and the state of medications in poor countries. The pharmaceutical companies can play an effective role in solving the medication problem (Dumit, 2012). The potential issues in the underdeveloped parts of Asia and Africa and the expected role of pharmaceutical companies in eliminating these issues have been discussed in this essay.

論文代寫：衛生保健
A large number of Asian and African countries lie in the poor, high population and low wage class of the world. Contacting with the research of Ashcroft (2002), the most people living in the poorest countries in Africa cannot afford the price of the essential medications. According to the actual situation in Africa, HIV is the most common problem in Africa. Kevin (2009) highlights a problem about the essential medication in Africa that the manufacturers of producing HIV medicine plays monopoly and control prices of drugs in the country. The data shows that if AIDS patients adhere to treatment, they may live an average of about 24 years after having AIDS. During this period more than $600,000 is required for medical expenses, which makes an average of $25,200 expenditure per year (Bor et al, 2013). This expenditure on medicine is unaffordable for the vast majority of AIDS patients. Not only the patients who live in this area cannot afford the treatment, but also the government of Africa cannot afford the huge money which is required to cure the HIV.